Background Azithromycin mass drug administration (MDA) to ages 1–59 months can reduce childhood mortality; however, more ...
Introduction Many neonatal deaths are avoidable using existing low-cost evidence-based interventions. This study evaluated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback